ParshipMeet Group Partners with TikTok, Giving Members More Tools for Self-Expression
The "Styrenics: Global Markets" report has been added to ResearchAndMarkets.com's offering.
LenderClose invests in internal efforts by expanding tech team to forge industry improvements in real estate lending.
Laurie Shane joins Aspen Insurance Holdings Limited ("Aspen") as new Group Head of Outwards Reinsurance and begins her role on June 1, 2021. Laurie will report to Brian Tobben, CEO Aspen Capital Partners.
Dassault Aviation Launches Falcon 10X, featuring Industry’s Largest Cabin and Most Advanced Technology on a Business Jet High-speed, ultra-long-range Falcon will come with innovative safety features derived from latest fighter technology Saint-Cloud, France, May 06, 2021 – Dassault Aviation today announced an all-new Falcon jet that will deliver a level of comfort, versatility and technology unmatched by any purpose-built business jet. Featuring a range of 7,500 nautical miles, the Falcon 10X will fly nonstop from New York to Shanghai, Los Angeles to Sydney, Hong Kong to New York or Paris to Santiago. Top speed will be Mach 0.925. “Today we are introducing a new benchmark in business aviation,” said Dassault Chairman and CEO Eric Trappier. “The Falcon 10X will offer an unrivalled passenger experience over both short- and long-duration flights, along with breakthrough safety features from Dassault’s frontline fighter technology. We have optimized every aspect of the aircraft with the passenger in mind and established a new level of capability for ultra-long-range aircraft.” The Falcon 10X will enter service at the end of 2025. Taking cabin modularity to unprecedented heights The 10X will have the biggest and most comfortable cabin on the market and offer greater modularity than any other aircraft in its class, with a selection of multiple interior configurations. The 10X is large enough to accommodate four cabin zones of equal length but owners can configure their cabin to create a truly customized interior, including for example, an expanded dining/conference area, a dedicated entertainment area with a large-screen monitor, a private stateroom with a queen-size bed or an enlarged master suite with a private stand-up shower. “The 10X will be more than just another big step forward in business aviation. It will be absolutely the best business jet available in the ultra-long-range category, and will remain so for a long time,” said Trappier. The 10X will have a cabin cross section larger than some regional jets. Its cabin will be 6-feet, 8-inches (2.03 m) tall and 9 feet, 1 inch wide (2.77 m). That will make it almost 8 inches (20 cm) wider and 2 inches (5 cm) taller than the widest and tallest purpose-built business jet flying today. Pressurization will also be the best on the market, with passengers experiencing a 3,000-foot cabin pressure altitude while flying at 41,000 feet. A next-generation filtration system will provide 100-percent pure air. The aircraft will be at least as quiet as the Falcon 8X, currently the quietest business jet in service. New structures, new materials, ultra-efficient power The 10X will feature an entirely new fuselage with extra-large windows—nearly 50 percent larger than those on the Falcon 8X. Thirty-eight windows will line the fuselage making for the brightest cabin in business aviation. The high-speed wing will be made of carbon fiber composites for maximum strength, reduced weight and minimum drag. Tailored for speed and efficiency, the very-high aspect ratio wing will be equipped with advanced, retractable high-lift devices offering superior maneuverability at low approach speeds. The twin-engine aircraft will be powered by business aviation’s most advanced and efficient engine, the in-development Rolls Royce Pearl® 10X. The 10X is the latest, largest and most powerful version of the Pearl series, delivering more than 18,000 pounds of thrust. A major advance in flight deck technology The Falcon 10X’s flight deck will set a new standard in intuitive design, with touch screens throughout the cockpit. A next-generation Digital Flight Control System, derived directly from Dassault’s latest military technology, will provide an unprecedented level of flying precision and protection, including a revolutionary, new single-button recovery mode. A single smart throttle will serve as the primary power control, connecting both engines to the Digital Flight Control System which will automatically manage the power of each engine as needed in different flight scenarios. Thanks to Dassault’s breakthrough FalconEye® combined vision system—the first to offer both enhanced and synthetic vision capabilities—combined with dual HUDs able to serve as primary flight displays, the 10X will be capable of operating in essentially zero ceiling/visibility conditions. “We have set the bar for our new Falcon incredibly high,” said Trappier. “But I can confidently say that we have put this aircraft at the top of the market.” * * * ABOUT DASSAULT AVIATION: With over 10,000 military and civil aircraft (including 2,500 Falcons) delivered in more than 90 countries over the last century, Dassault Aviation has built up expertise recognized worldwide in the design, development, sale and support of all types of aircraft, ranging from the Rafale fighter, to the high-end Falcon family of business jets, military drones and space systems. In 2020, Dassault Aviation reported revenues of €5.5 billion. The company has 12,440 employees. dassault-aviation.com PRESS CONTACTS: Falcon CommunicationsVadim Feldzer - Tel +33 (0)1 47 11 44 13 - firstname.lastname@example.org Corporate Communications Stéphane Fort - Tel +33 (0)1 47 11 86 90 - email@example.com Mathieu Durand - Tel +33 (0)1 47 11 85 88 - firstname.lastname@example.org HD photos: mediaprophoto.dassault-aviation.com HD videos: mediaprovideo.dassault-aviation.com Attachment PR_Dassault Aviation_Falcon 10X
Square Enix, Bandai Namco and and Sega are will all participate in this year's virtual E3 event, which begins on June 12th.
LOS ANGELES, May 06, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 18, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Acadia Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD) securities between June 15, 2020 and April 4, 2021, inclusive (the “Class Period”). If you suffered a loss on your Acadia investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/acadia-pharmaceuticals-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at email@example.com to learn more about your rights. Acadia is a biopharmaceutical company that develops a drug called pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia, as well as an adjunctive treatment for major depressive disorder. In June 2020, Acadia submitted a supplemental New Drug Application (“sNDA”) with the U.S. Food and Drug Administration (“FDA”) to expand pimavanserin’s label to include treatment for dementia-related psychosis. On March 8, 2021, the Company revealed that, as part of its ongoing review of the sNDA, the FDA “has identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.” On this news, Acadia’s stock price fell $20.76 per share, or 45.35%, to close at $25.02 per share on March 9, 2021, thereby injuring investors. On April 5, 2021, pre-market, the Company disclosed receipt of a Complete Response Letter (“CRL”) from the FDA indicating that the pimavanserin sNDA could not be approved in its current form. Specifically, the press release stated that the CRL “cited a lack of statistical significance in some of the subgroups of dementia, and insufficient numbers of patients with certain less common dementia subtypes as lack of substantial evidence of effectiveness to support approval.” On this news, Acadia’s stock price fell $4.41 per share, or 17.23%, to close at $21.18 per share on April 5, 2021, thereby injuring investors further. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (2) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (3) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. Follow us for updates on LinkedIn, Twitter, or Facebook. If you purchased or otherwise acquired Acadia securities during the Class Period, you may move the Court no later than June 18, 2021 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts Glancy Prongay & Murray LLP, Los Angeles Charles Linehan, 310-201-9150 or 888-773-9224 email@example.com www.glancylaw.com
AIStorm’s charge domain AI-in-Sensor technology uses Tower Semiconductor's Hi-K VIA capacitor memory to enable best-in-class real-time machine learning for the $7B edge imager market. HOUSTON, Tx. and Migdal HaEmek, Israel—May 6, 2021— AIStorm and Tower Semiconductor today announced that AIStorm’s new AI-in-Imager products will use AIStorm’s electron multiplication architecture and Tower’s Hi-K VIA capacitor memory instead of digital calculations to perform AI computation at the pixel level. This saves the silicon real estate, multiple die packaging costs and power required of competitive digital systems including eliminating the need for input digitization. The Hi-K via capacitors reside in the metal layers and thus allow the AI to be built directly into the pixel matrix without any compromise on pixel density or size. Always-on-Imagers are capable of drawing negligible power in idle mode until detection of specific situations such as “wakeup on… fingerprint… face… action…behavior… gesture… person… or driving event”. In addition, they perform machine learning within the device after wakeup, eliminating the need for additional components or co-packaged processors. The AI edge market is expected to grow from $6.72 billion in 2022 to $66.3 billion by 2025 in deep chip learning. Next generation handsets, IoT devices, cameras, laptops, VR, gaming devices and wearables will directly benefit from AIStorm’s AI-in-sensor technology with superior cost and performance compared to other AI edge solutions on the market. “This new imager technology opens up a whole new avenue of “always on” functionality. Instead of periodically taking a picture and interfacing with an external AI processor through complex digitization, transport and memory schemes, AIStorm’s pixel matrix is itself the processor & memory. No other technology can do that,” said Dr. Avi Strum, SVP of Sensors and Displays BU at Tower Semiconductor. In existing solutions, AI processors usually reside outside of the pixel matrix. This is the reason “Always On” imaging solutions need to continuously detect pixel changes and forward digital information to memory and an AI subsystem located outside the imager. This causes many false alerts and high-power consumption. Whether GPU based or PIM based, significant silicon area is associated with memory storage, hence high cost. AIStorm's solution is different. Electrons are multiplied directly instead of being converted to a digital numbers through the use of memory which is suspended above the silicon in the metals, a feature enabled by using Tower Semiconductor's low leakage VIA Capacitor technology. This capability for local AI pixel coupling adds a new dimension to edge imaging allowing immediate intelligent (AI) response to pixel changes for the first time. To complement its hardware, AIStorm has built mobile models, under the MantisNet & Cheetah families, that use the direct pixel coupling of the AI matrix to offer sub-100uW “always on” operation with best-in-class latencies, and post wakeup processing of up to 200 TOPs/W. About AIStormAIStorm is the pioneer and leader in AI-in-Sensor charge domain processing, which eliminates the latency, power and cost associated with competitive AI solutions at the EDGE. AIStorm is headquartered in Houston, Texas, with offices in Graz, Austria, Budapest, Hungary, Chardon, Ohio, Nashua New Hampshire, Toronto, Canada and Hsinchu, Taiwan. For more information, visit https://aistorm.ai. About Tower Semiconductor Tower Semiconductor Ltd. (NASDAQ: TSEM, TASE: TSEM), the leader in high-value analog semiconductor foundry solutions, provides technology and manufacturing platforms for integrated circuits (ICs) in growing markets such as consumer, industrial, automotive, mobile, infrastructure, medical and aerospace and defense. Tower Semiconductor’s focuses on creating positive and sustainable impact on the world through long term partnerships and its advanced and innovative analog technology offering, comprised of a broad range of customizable process platforms such as SiGe, BiCMOS, mixed signal/CMOS, RF CMOS, CMOS image sensor, non-imaging sensors, integrated power management (BCD and 700V), and MEMS. Tower Semiconductor also provides world-class design enablement for a quick and accurate design cycle as well as Transfer Optimization and development Process Services (TOPS) to IDMs and fabless companies. To provide multi-fab sourcing and extended capacity for its customers, Tower Semiconductor operates two manufacturing facilities in Israel (150mm and 200mm), two in the U.S. (200mm) and three facilities in Japan (two 200mm and one 300mm) through TPSCo. For more information, please visit www.towersemi.com. AIStorm Media ContactTim Cox, ZingPR for AIStormtim@zingpr.com Tower Semiconductor Company Contact: Orit Shahar | +972-74-7377440 | firstname.lastname@example.org Attachment AI Storm_Tower_Release_05062021
(Bloomberg) -- New York City is in talks to offer free vaccines to tourists as a way to encourage them to visit, Mayor Bill de Blasio said. Pfizer Inc. and BioNTech SE have capacity to make as many as 3 billion doses of their vaccine this year, more than double the amount the partners predicted six months ago.Germany said U.S. support for a waiver of patent protections for vaccines would create “severe complications” for production, as the proposal headed to the World Trade Organization. India reported its highest-ever daily tally of 412,262 new virus cases and also a record 3,980 deaths. The governors of Tokyo and Osaka called for their virus emergencies to be extended, with Japanese Prime Minister Yoshihide Suga set to decide Friday.Key DevelopmentsGlobal Tracker: Cases near 155.3 million; deaths exceed 3.24 millionVaccine Tracker: More than 1.21 billion doses have been givenModerna Covid booster shots prove effective against variants (Video)Vaccines work on this India variant. Experts fret about the nextA new wave of vaccines is coming, and they’re not all also-ransBroken ventilators add momentum to ‘right to repair’ movementSubscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click CVID on the terminal for global data on cases and deaths.Merkel Opposes Waiving Vaccine Patents (11:28 a.m. NY)The U.S. plan would create “severe complications” for the production of vaccines, according to German government spokeswoman.NYC Pitches Vaccine Tourism (10:41 a.m. NY)New York Mayor Bill de Blasio said he is working with state officials to offer free vaccines to visitors as a way to encourage them to visit and spur tourism.Mobile vans will bring Johnson & Johnson one-dose shots to Times Square, Brooklyn Bridge Park and other popular locations, de Blasio said Thursday during a virus briefing.“We think this is a positive message to send to tourists,” the mayor said. “Come here and we’re going to take care of you.”The city plans a $30 million marketing blitz to recharge its tourism industry. Capacity restrictions on restaurants, stores and shows will be lifted on May 19 as Covid-19 cases decrease and vaccinations increase, Governor Andrew Cuomo said this week. Broadway tickets for September shows went on sale today.Pfizer Ups Production Target (10:38 a.m. NY)Pfizer Inc. and BioNTech SE have capacity to make as many as 3 billion doses of their Covid-19 vaccine this year, more than double the amount the partners had predicted less than six months ago.The partners will further increase their capacity for 2022 to more than 3 billion doses, BioNTech said in an e-mailed statement.The increase is the latest in a series of production target boosts and comes amid increased demand for messenger RNA Covid vaccines around the world.India Variant Spreads in Africa (10:31 a.m. NY)The coronavirus strain circulating in India has been detected in three African countries, according to the head of the Africa Centres for Disease Control and Prevention.Authorities in Kenya, Uganda and Morocco have reported the presence of the variant known as B.1.617 that is overwhelming the health system in India, Africa CDC’s director, John Nkengasong, said in an online briefing Thursday. Five cases have been found in Kenya and one in Uganda, while the Moroccan government is “investigating some cases there,” he said.Fearing an influx of infections and mindful of B.1.617, Nigeria, Kenya, Uganda and Tanzania are among countries that have temporarily banned flights from India. Rwanda Eyes Vaccine Plant (10:07 a.m. NY)Rwandan President Paul Kagame said his country is in talks to establish the first mRNA vaccine plant in Africa as the continent battles the coronavirus pandemic. He did not give details.Africa has few manufacturing facilities of any kind and most that do exist can only package and distribute the inoculations -- so called fill-finish facilities -- rather than make the ingredients needed for the shots.Vaccines Donated to Olympics (9:30 a.m. NY)Tokyo Olympic athletes and delegations will be able to receive Covid-19 vaccine doses donated by Pfizer Inc. and BioNTech SE as organizers push ahead with preparations for the delayed games.The International Olympic Committee signed an agreement with the companies to donate the doses, with the first delivery expected to begin at the end of this month, according to a statement from the drugmakers on Thursday. The statement did not specify the number of doses.Hungary’s Population Falls (9:15 a.m. NY)Hungary’s 2020 population drop, as measured by deaths exceeding births, was the biggest in more than a century with the eastern European Union one of the world’s worst-hit by the coronavirus pandemic.The plunge of 48,667 was the highest since 1918, when the Spanish flu and World War I were the biggest contributing factors, figures released Wednesday showed.Russia Approves One-Dose Shot (7:59 a.m. NY)Russia approved a single-dose version of the Sputnik V Covid-19 vaccine after it showed almost 80% efficacy, according to the state-run fund that backed its development.The 79.4% efficacy rate of the vaccine, called Sputnik Light, is based on an analysis of real-world data rather than a standard clinical trial, and interim results from final-stage study are expected later this month, according to a statement from the Russian Direct Investment Fund. Early and mid-stage studies showed no serious adverse events, RDIF said.U.S. Patent Shock Roils Pharma (7:21 a.m. NY)The U.S.’s sudden support for a waiver of patent protections for Covid-19 vaccines headed to the World Trade Organization, setting the stage for potentially thorny negotiations over sharing the proprietary know-how needed to boost global supplies of the life-saving shots.“In terms of how soon the WTO can deliver -- that literally depends on the WTO members, collectively, being able to deliver,” U.S. Trade Representative Katherine Tai said in an interview Wednesday. “I am the first one to admit that what we are leaning into is a process that is not going to be easy.”With the European Union and China signaling a willingness to take part in the debate after the Biden administration’s shock announcement, stock prices tumbled worldwide.Moderna Reported Effective for Teens (7:18 a.m. NY)Moderna Inc. said studies of its Covid vaccine in teenagers showed that it was 96% effective and raised its product sales projections for the year as it reported its first-ever profitable quarter.Germany Backs Lockdown Exemptions (7:17 a.m. NY)German residents who have been fully vaccinated against the coronavirus will be exempt from most lockdown rules under legislation approved Thursday in the lower house of parliament.The law, which also covers people who have recovered from Covid-19, is set to be voted on by the upper house on Friday and will likely take effect this weekend. For people considered immune, mandatory tests for trips to the hairdresser and non-essential stores will no longer be required, and the need to comply with curfews and quarantine rules will be waived.EU Defends Vaccination Drive (6:15 a.m. NY)The head of the European Union’s executive arm mounted a spirited defense of the bloc’s Covid-19 vaccination campaign, taking a swipe at countries like the U.S. and the U.K. as she hailed her region as the world’s top vaccines exporter.“It is clear that our European vaccination campaign is a success,” European Commission President Ursula von der Leyen told an online conference. “What counts is the steadily increasing daily delivery of vaccines to our people -- and to the world.”Biden’s Vaccine Path Gets Tougher (6 a.m. NY)President Joe Biden’s government is now giving an average of 2.13 million shots a day, down from 3.37 million about three weeks ago. And on Tuesday, which has the lowest shots of any day of the week, fewer than a million were given for the first time since February.In response, the administration announced this week that it would concentrate more on smaller clinics and mobile sites in rural areas, while planning to wind down mass-vaccination sites.Hungary Touts Pfizer to Buoy Campaign (5:28 p.m. HK)Hungary will make Pfizer and Moderna Covid shots widely available to the public as the nation seeks to keep up the pace of one of the European Union’s fastest vaccination campaigns.Authorities will make available as many as 180,000 vaccines from the two companies each week on an online vaccine registration platform, most of them from Pfizer, Cabinet Minister Gergely Gulyas said at a briefing on Thursday.Australia Clots Tied to Astra (2:25 p.m. HK)Five additional cases of a rare type of blood clot were identified in recipients of AstraZeneca Plc’s Covid-19 vaccine in Australia. All are receiving treatment, the company said in a statement Thursday. More cases of so-called thrombosis with thrombocytopenia are expected as the vaccine is offered to people older than 50 in Australia, said Katie Flanagan, president-elect of the Australasian Society for Infectious Diseases.Tokyo Emergency May Lengthen (2:06 p.m. HK)Japanese Prime Minister Yoshihide Suga said he would decide Friday on extending a state of emergency for Tokyo and three other regions, as he tries to stem a surge in Covid-19 infections ahead of the capital hosting the Olympics from July.Tokyo wants to extend a virus emergency currently in place and will soon seek approval for the move from Prime Minister Yoshihide Suga, in a bid to stem a surge in infections ahead of the capital hosting the Olympics from July.The major metro area of Osaka, where infection numbers have reached record highs in recent days, is also set to seek an extension, with Governor Hirofumi Yoshimura saying he has no other option.Sydney Imposes New Curbs (9:46 a.m. HK)Restrictions on gatherings are being imposed in Sydney and surrounding areas due to two Covid-19 cases detected in Australia’s most-populous city.From 5 p.m. Thursday, the maximum number of people allowed into homes will be 20, while singing and dancing in all indoor venues except those hosting weddings will be banned, New South Wales Premier Gladys Berejiklian told reporters. Masks will be compulsory on public transport and in all public indoor venues, such as retail, theaters, hospitals and aged-care facilities. The restrictions will last until at least the end of the weekend.Hong Kong Vaccinations Pass 1 Million (9:03 a.m. HK)The number of people who have received their first Covid-19 vaccine dose has exceeded 1 million on Wednesday, Hong Kong’s government said. The vaccination program has been running since Feb, 26.Still, only about 13.4% of the Hong Kong population has received at least one dose, according to Bloomberg’s Covid-19 Vaccine Tracker. That’s still well behind rival financial hubs like Singapore, London and New York.(An earlier version of this story corrected the name of the virus)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Demo Shows How Ericsson and Cradlepoint Are Working Together to Use Network Slicing Technologies to Protect Business-Critical Enterprise 5G Flows From CongestionBOISE, Idaho and SANTA CLARA, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Cradlepoint, a global leader in cloud-delivered 4G and 5G wireless network edge solutions, today presented a proof-of-concept demonstration of enterprise 5G network slicing at its 2021 Global Partner Summit event. The demo, performed at Ericsson's Silicon Valley D-15 Labs, illustrates how 5G network slicing can protect business-critical application data from surrounding congestion while ensuring a steady throughput rate. This network slicing proof-of-concept is one of the first integrations of Ericsson technology with Cradlepoint 5G edge routers and highlights the acquisition's potential to unlock 5G capabilities for enterprises and help accelerate adoption. Ericsson D-15 Labs Cradlepoint performed the proof-of-concept at the Ericsson D-15 Labs, a state-of-the-art innovation center located in the heart of Silicon Valley. Inspired by Ericsson's first workshop on Drottninggatan 15 in Stockholm, D-15 allows customers and partners to collaborate with a dynamic ecosystem of experts and an ultra-low latency 5G-powered platform. Enterprise 5G Network Slicing Proof-of-Concept The lab testbed consists of a Cradlepoint R1900 5G Mobile Router, running in Standalone (SA) mode, connecting to an Ericsson 5G Core and 5G Radio Access Network (RAN) with network slicing and Slice-Aware Quality of Service (QoS) configured. Several PCs running traffic-generator software emulate business-critical and best-effort data across a 5G connection while a mobile device injects congestion into the network. The demonstration shows the best-effort flows slowing to a crawl as the RAN and 5G connection becomes congested. In contrast, the business-critical data is protected and maintains a steady throughput rate. "Demonstrating Ericsson network slicing technology working with a Cradlepoint 5G router to protect business-critical flows is incredibly important to accelerating enterprise adoption of 5G," said Marc Bresniker, vice president of product management at Cradlepoint. "With Ericsson, we're taking the first step in enabling this technology and bringing MPLS-like traffic management capabilities to 5G that enterprises will require as they cut-the-cord and shift more applications to Wireless WANs." Why Network Slicing is Essential to Enterprise 5G Adoption As enterprises embrace Wireless WAN and 5G as essential infrastructure for connecting fixed sites, field forces, vehicles, and IoT devices, they need to support a mix of business-critical, lower-priority, and best-effort traffic over 5G. Additionally, they need to ensure that their critical applications are not affected by "noise neighbor" traffic on a shared 5G RAN. Ericsson's network-slicing technology, interoperating with Cradlepoint 5G routers, addresses both challenges and can ensure that business-critical application throughput is protected. "We first started to develop network slicing technology with enterprise frontrunner partners here in D-15 a few years ago,” said Jan Söderström, head of Ericsson's Silicon Valley technology office. "Our goal was to present this innovation to the industry and share a glimpse of the future. It was radical but something which we did for the industry. Today I'm thrilled that – together with Cradlepoint – we have demonstrated how to protect business-critical enterprise application flows in the 5G mobile network with network slicing." What to Expect Next Cradlepoint is working with Ericsson to deliver integrated enterprise 5G network slicing functionality by the end of 2021. Additionally, as a prerequisite, communication service providers need to roll out 5G standalone (SA) mode, which is underway on various mobile networks around the world. Learn More About Ericsson End-to-End 5G Network Slicing As a leader in 5G networks technology, Ericsson brings the latest innovations in End-to-End 5G Network Slicing, partnering with global operators in various commercial and proof-of-concept trials across many industry segments. Ericsson's network slicing technology includes RAN, transport, core, Operations Support Systems (OSS), and Business Support Systems (BSS). The end-to-end approach delivers the automation and monetization capabilities to meet the needs of various use cases. Click here to learn more. About Cradlepoint Cradlepoint is a global leader in cloud-delivered 4G and 5G wireless network edge solutions. Cradlepoint's NetCloud™ platform and cellular routers deliver a pervasive, secure, and software-defined Wireless WAN edge to connect people, places, and things – anywhere. More than 25,000 businesses and government agencies worldwide, including many Global 2000 organizations and top public sector agencies, rely on Cradlepoint to keep mission-critical sites, points of commerce, field forces, vehicles, and IoT devices always connected. Cradlepoint was founded in 2006, acquired by Ericsson in 2020, and operates today as a standalone subsidiary within Ericsson's Business Area Technologies and New Businesses. Cradlepoint headquarters is in Boise, Idaho, with development centers in Silicon Valley and India and international offices in the UK and Australia. www.cradlepoint.com Cradlepoint Media InquiriesHighwire PRTravis Barend585.email@example.com A video accompanying this release is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/d5e3253f-26aa-41cc-a4bc-3fc04e43e970
Atlanta, May 06, 2021 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray”) (NYSE: GTN) announced today that the Radio Television Digital News Association (RTDNA) awarded a combined 57 regional Edward R. Murrow awards for excellence in journalism to 26 of Gray’s local stations, led by nine separate awards to WVUE in New Orleans. Among the highest honors: Three awards for Overall Excellence—the highest honor bestowed—to WVUE in New Orleans; WKYT in Lexington, Kentucky; and KWQC in Davenport, Iowa.Six awards for Newscast to WVUE in New Orleans; WAFB in Baton Rouge, Louisiana; WMTV in Madison, Wisconsin; WKYT in Lexington, Kentucky; WTVG in Toledo, Ohio; and WWBT in Richmond, Virgina.Four awards for Investigative Reporting to WVUE in New Orleans; Honolulu-based Hawaii News; WRDW in Augusta, Georgia; and WBAY in Green Bay, Wisconsin.Two awards for Excellence in Innovation to WKYT in Lexington, Kentucky; and KYTV in Springfield, Missouri. “We are very proud of the excellent journalistic and investigative achievements of Gray’s local television stations in markets large and small, from coast to coast,” said Gray Chairman and CEO Hilton H. Howell Jr. “Today’s announcement that 26 of our stations received 57 Regional Murrow awards provides an especially gratifying recognition of truly great work by these stations’ industry peers.” RTDNA has been honoring outstanding achievements in electronic journalism with the Edward R. Murrow Awards since 1971. Murrow’s pursuit of excellence in journalism embodies the spirit of the awards that carry his name. Gray’s regional award winners will move on to the national round of the annual competition. National awards will be announced later this year. About Gray: Gray Television is a television broadcast company headquartered in Atlanta, Georgia. Gray is the largest owner of top-rated local television stations and digital assets in the United States (“U.S.”). Gray currently owns and/or operates television stations and leading digital properties in 94 television markets that collectively reach approximately 24% of U.S. television households. During 2020, Gray’s stations were ranked first in 70 markets, and ranked first and/or second in 86 markets, as calculated by Comscore’s audience measurement service. Gray also owns video program production, marketing, and digital businesses including Raycom Sports, Tupelo Honey, and RTM Studios, the producer of PowerNation programs and content, and is the majority owner of Swirl Films. # # # CONTACT: Contact: Sandy Breland, Senior Vice President, 504-352-4019
ADMQ-RRISD ADMQ FORT WORTH, TX, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ADM Endeavors, Inc. (OTCQB: ADMQ) announced today that our wholly owned subsidiary, Just Right Products, Inc., has been awarded a new contract with Round Rock ISD for Screen Printing and Embroidery Services. Round Rock Independent School District is a school district headquartered in the city of Round Rock, Texas. As of Fall 2019, the school district is serving more than 51,000 students, pre-kindergarten through grade 12. Round Rock ISD includes 55 schools that serve students in southern Williamson County, northwest Travis County, the city of Round Rock and portions of the cities of Austin and Cedar Park. Round Rock Independent School District - https://roundrockisd.org/ CEO Marc Johnson said, “David Kirk, our Vice President of Marketing, will take the lead on developing this new opportunity. Round Rock is a wonderful area and we look forward to working with the amazing people in the Round Rock ISD.” About ADMQ: Since 2010, our wholly owned subsidiary, Just Right Products, Inc., has been consistently increasing sales, with sales topping $5.1 million in 2020. The Company sells “Anything With A Logo” on its website, www.JustRightProducts.com, developing products ranging from unique business cards to coffee cups, T-shirts to boots, with tens of thousands of other unique products from which to select. Just Right Products, Inc. operates a diverse vertical integrated business in the Dallas/Fort Worth area, consisting of a retail sales division, screen print production, embroidery production, digital production, import wholesale sourcing, and uniforms. www.admendeavors.comwww.fwpromo.comwww.justrightproducts.comwww.facebook.com/groups/admqshareholdershttps://fortworth.academicoutfitters.com/ Forward Looking Statement: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. Any statements that are not historical facts contained in this press release are "forward-looking statements" that involve a number of risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Words such as “strategy,” “expects,” “continues,” “plans,” “anticipates,” “believes,” “would,” “will,” “estimates,” “intends,” “projects,” “goals,” “targets” and other words of similar meaning are intended to identify forward-looking statements but are not the exclusive means of identifying these statements. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions or economic conditions with respect to the retail industry, the COVID-19 pandemic, the performance of management, actions of government regulators, vendors, and suppliers, our cash flows and ability to obtain financing, competition, general economic conditions and other factors that are detailed in our filings with the Securities and Exchange Commission. We intend that all forward-looking statements be subject to the safe-harbor provisions. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: ADM Endeavors, Inc. | 817.840.6271 Paul Knopick | firstname.lastname@example.org| 940.262.3584 Attachment ADMQ-RRISD
LOS ANGELES, May 06, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to email@example.com. LifeMD, Inc. (NASDAQ: LFMD)Class Period: January 19, 2021 – April 13, 2021Lead Plaintiff Deadline: June 15, 2021 Shareholders with $100,000 losses or more are encouraged to contact the firm Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that many of LifeMD’s executives were associated with Redwood Scientific when it was charged for unlawful autoshipping, abusive telemarketing, and false claims, and that they employed similar practices at the Company; (2) that LifeMD engaged in autoshipping products to unwilling customers to record recurring revenue and the Company made it difficult to cancel such subscriptions; (3) that certain of the purportedly licensed physicians on the Company’s platform were not in fact licensed and faced disciplinary action; (4) that, as a result of the foregoing practices, the Company was reasonably likely to face regulatory scrutiny and/or reputational harm; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Romeo Power Inc. (NYSE: RMO)Class Period: October 5, 2020 – March 30, 2021Lead Plaintiff Deadline: June 15, 2021 Shareholders with $50,000 losses or more are encouraged to contact the firm The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Romeo Power had only two battery cell suppliers, not four; (2) the future potential risks that defendants warned of concerning supply disruption or shortage had already occurred and were already negatively affecting Romeo Power’s business, operations and business prospects; (3) Romeo Power did not have the battery cell inventory to accommodate end-user demand and ramp up production in 2021; (4) Romeo Power’s supply constraint was a material hindrance to Romeo Power’s revenue growth; and (5) Romeo Power’s supply chain for battery cells was not hedged, but in fact, was totally at risk and beholden to just two battery cell suppliers and the spot market for their 2021 inventory; and (6) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. Credit Suisse Group AG (NYSE: CS)Class Period: October 29, 2020 – March 31, 2021Lead Plaintiff Deadline: June 15, 2021 The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Credit Suisse’s co-mingling of its lending, asset management, and private wealth management functions and imprudently aggressive pursuit of fees had materially diminished the Company’s ability to properly assess and manage its own risk exposure to high-risk clients and potential liabilities from client losses; (2) that Credit Suisse had ignored numerous red flags in connection with the Greensill funds, such as suspicious shipment activities during an internal compliance check, and overrode the concerns of the Company’s in-house credit-structuring team in packing and selling billions of dollars’ worth of Greensill-linked securities to investors; (3) that Credit Suisse had conspired to allow Archegos to covertly take on billions of dollars in excessively concentrated and risky positions by utilizing highly leveraged total return swaps, placing the risk of loss associated with these positions on Credit Suisse and its investors; (4) that Credit Suisse was understating its exposure to risk and thus overstating its Tier 1 capital ratios in its public statements; and (5) that Credit Suisse’s internal controls were inadequate to ensure that the Company’s potential liability to customers and losses arising from its exposure to customer losses were properly accounted for, managed and disclosed to investors. Follow us for updates on Twitter: twitter.com/FRC_LAW. To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to firstname.lastname@example.org, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, email@example.com
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and CompaniesSUNNYVALE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- DrChrono Inc., the company developing the essential platform and services for modern medical practices, announced today that it has been selected as the winner of the “Best Electronic Health Record Service” award in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market. Thousands of physicians and medical professionals across the country use DrChrono's open platform for electronic health record (EHR), practice management, medical billing, revenue cycle management and telehealth needs. DrChrono’s high level of innovation in the EHR space is in large part the result of a robust, open API and marketplace of applications and services. From outcome tracking to AI-based scheduling tools, the API’s simple setup and powerful functionality has afforded hundreds of developers the opportunity to create innovative digital health apps and solutions. DrChrono’s open FHIR API also supports health records on iPhone, allowing patients to consolidate their health records across institutions and securely transfer their data out of DrChrono into the Apple Health app on iPhone. The Health Records feature is part of the Health app, which also shows activity, heart rate, nutrition and other health data integrated into iPhone, Apple Watch and HealthKit-enabled third-party apps. “Mobility is a central value for our EHR platform, and DrChrono continues to evolve and update our platform so that patients and providers can leverage the mobile capabilities of the various Apple devices that are widely used by physicians and medical practices,” said Daniel Kivatinos, Co-Founder and COO of DrChrono. “EHR innovation is more critical than ever, and we’re thrilled to receive this 2021 MedTech Breakthrough Award in recognition of our innovation in this space.” The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,850 nominations from over 17 different countries throughout the world. “Anywhere, anytime access to health and medical records has been discussed for years, and DrChrono is innovating in the digital health market to make this a reality, modernizing the medical practice of the future and online Patient Health Records,” said James Johnson, managing director of MedTech Breakthrough. “We extend our sincere congratulations to the entire DrChrono team on being our pick for ‘Best Electronic Health Record Service’ for 2021.” DrChrono’s EHR platform is used by thousands of physicians and has over 27 million patients under the care of DrChrono providers. The platform has facilitated millions of appointments and the processing of more than $11 billion of medical billing to date. DrChrono also offers a fully integrated telemedicine solution for its network of providers including Video Visits that allow physicians to view medical records and perform other tasks, such as e-prescribing, during an appointment. DrChrono is also the first EHR to offer an all-in-one telehealth app experience on iOS and iPadOS. About DrChronoDrChrono develops the essential platform and services for modern medical practices to make care more informed, more interactive, and more personalized. The open platform powers electronic health record (EHR), practice management, medical billing, and revenue cycle management solutions for thousands of physicians and millions of patients, and is fully extensible via a robust API and marketplace of applications and services. The platform is facilitating millions of patient appointments and is processing billions of dollars in medical billing. For more information about DrChrono, visit www.drchrono.com. About MedTech BreakthroughPart of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com. Media Contact:Gina RezendesBig Swing Communications firstname.lastname@example.org
Rapala VMC CorporationStock Exchange Release6.5.2021 RAPALA VMC CORPORATION: Share repurchase 6.5.2021 In the NASDAQ OMX Helsinki Trade date 6.5.2021 Bourse trade Buy Share RAP1V Amount 2,000SharesAverage price/ share 8,7722EURTotal cost 17,544.40EUR Company now holds a total of 361 609 shares including the shares repurchased on 6.5.2021 On behalf of Rapala VMC Corporation Nordea Bank Finland Plc Janne Sarvikivi Sami Huttunen For further information: Olli Aho Investor Relations, tel. +358 9 7562 540 www.rapalavmc.com Attachment RAP1V_6_5_trades
SAN ANTONIO, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- The Hispanic Association of Colleges and Universities has announced more than 50 workshops will be offered virtually under the theme, “35 Years of Championing Hispanic Higher Education Success,” as part of its 35th Annual Conference, taking place virtually, October 25-27, 2021. General conference workshops will include topics of interest to Hispanic-Serving Institutions and colleges and universities serving Hispanic students. Topics are offered under the following six tracks: Grants and Fundraising Opportunities; Partnerships that Work; Executive Leadership for Presidents, CEOs and Trustees; Championing Academic Success for Hispanic Students, Research and Practice; Advocacy and Policy; and International Partnerships. A separate student track will be offered for undergraduate students under HACU’s ¡Adelante! Leadership Institute, taking place Oct. 24-27. Special features of the conference will include the following: Opening Plenary with HACU President and CEO Antonio R. Flores who will deliver the State of HACU, an International Plenary and a Town Hall. HACU will also recognize honorees that have contributed to improving opportunities for college students. A virtual exhibitor experience will also be included. For a complete agenda and list of workshops, click here HACU’s premier conference on Hispanic higher education provides a unique forum for the sharing of information and ideas for the best and most promising practices in the education of Hispanics and promotes and expands partnerships and strategic alliances for collaboration between HACU-member institutions and public- and private-sector organizations. The regular lineup of pre-and post-conference events will include: Oct. 20 – 20th Annual Latino Higher Education Leadership Institute Oct. 21 – Seventh PreK-12/Higher Education Collaboration Symposium Oct. 28 – 10th Annual Deans' Forum on Hispanic Higher Education Registration for HACU’s 35th Annual Conference and pre-and post-conference events is available at hacu.net. Early bird rates are available through Sept. 24. Advertising, Exhibitor, and Sponsorship opportunities are available. Special thanks to all 35th Annual Conference sponsors. About HACUThe Hispanic Association of Colleges and Universities, founded in 1986, represents more than 500 colleges and universities in the United States, Latin America, Spain and school districts throughout the U.S. HACU is the only national association representing existing and emerging Hispanic-Serving Institutions (HSIs). The Association’s headquarters are located in San Antonio, Texas, with regional offices in Sacramento, California and Washington, D.C. This year, HACU celebrates its 35th Anniversary since its founding. CONTACT:Norma Jean Revilla-GarciaExecutive Director of Communications and MarketingHispanic Association of Colleges and Universities210.email@example.com
GeoVax Chairman & CEO David Dodd to Participate in Panel Discussion ATLANTA, GA, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancers, announced today that management will participate at the Benzinga Global Small Cap Conference being held May 13-14, 2021. David Dodd, GeoVax’s Chairman and CEO, will deliver his corporate presentation at 9:50am ET on May 13. Mr. Dodd will also participate in a panel discussion titled “Investing Post COVID – Back to the Fundamentals” at 11:50am ET on May 13. The panel will discuss healthcare investing in the post COVID world. Investors can also request a one-on-one meeting with Mr. Dodd to be arranged following the conclusion of the conference. Investors can register for the conference here: https://www.benzinga.com/events/small-cap/global/ About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On this platform, MVA, a large virus capable of carrying several vaccine antigens, expresses proteins that assemble into VLP immunogens in the person receiving the vaccine. The production of VLPs in the person being vaccinated can mimic virus production in a natural infection, stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines can elicit durable immune responses in the host similar to a live-attenuated virus, while providing the safety characteristics of a replication-defective vector. GeoVax’s current development programs are focused on preventive vaccines against COVID-19, HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, as well as therapeutic vaccines against multiple cancers. The Company has designed a preventive HIV vaccine candidate to fight against the subtype of HIV prevalent in the commercial markets of the Americas, Western Europe, Japan, and Australia; human clinical trials for this program are managed by the HIV Vaccine Trials Network (HVTN) with the support of the National Institutes of Health (NIH). GeoVax’s HIV vaccine is also part of two separate collaborative efforts to apply its innovative gene therapy approach toward a functional cure for HIV. Contact: GeoVax Labs, Inc. firstname.lastname@example.org 678-384-7220
Innovate BC and The B.C. Government Deliver First Ever Aquaculture Innovation AwardsVancouver, May 06, 2021 (GLOBE NEWSWIRE) -- Innovate BC and the B.C. government announced the award of $325,000 to three BC aquaculture innovations in yesterday’s inaugural Aquaculture Innovation Awards event. There were two $150,000 awards, selected by the judges, and one $25,000 fan favourite award, voted on live by the audience. Top 10 finalists, selected through a rigorous judging process, pitched at the Award event and then responded to questions from selected customer advisors. The customer advisors could see first-hand upstream innovations as well as provide real-world context to the problems the Top 10 were trying to solve. The three award recipients are Poseidon Ocean Systems, ThisFish and Fan Favourite Industrial Plankton. Poseidon Ocean Systems Ltd Poseidon Ocean Systems’ Flowpressor Technology Platform reduces diesel fuel consumption by 55% in real-world testing. It is an innovative clean compressor technology specifically designed for aquaculture to produce compressed air to run aeration systems, oxygen generators, and feed systems. Award: $150,000 ThisFish Inc. ThisFish's Tally traceability software for the aquaculture sector enables significant improvements in time and quality through automation and predictive analytics. It links data from farm to factory through IoT devices and tablet computers and uses machine learning algorithms. Award: $150,000 Industrial Plankton Inc. Industrial Plankton develops and produces algae bioreactors for live feed production in aquaculture hatcheries. Their technology is currently used in 20 countries, primarily in shellfish and shrimp hatcheries. Fan Favourite Award: $25,000 The Aquaculture Innovation Awards fund innovations that solve challenges faced by BC aquaculture. The awards encourage sustainable growth, competitiveness and adaptability of BC aquaculture. Read more on the Top 10 finalists here. Quotes Raghwa Gopal, President + CEO, Innovate BC “We’re thrilled to work with the BC government in this first-of-its kind event. Innovate BC excels at identifying innovation that provides industry with benefits to fuel and sustain growth. And we believe matching BC innovation with traditional sectors amplifies the benefits felt by the entire BC innovation ecosystem.” Fin Donnelly, Parliamentary Secretary for Fisheries and Aquaculture “B.C. is a leader in both developing innovative seafood technology and production, and we’re showcasing those local ideas and solutions through our new BC Aquaculture Innovation Awards. By fostering new and exciting partnerships between our aquaculture and technology sectors we are providing economic opportunities while strengthening both our food system and clean technology for future generations.” Ravi Kahlon, Minister of Jobs, Economic Recovery and Innovation “These awards are an important opportunity to recognize excellence in innovation in B.C.’s aquaculture sector. Cutting-edge technologies like these will help the industry become more globally competitive, spur job creation and drive economic development, which helps all British Columbians. Congratulations on your successes.” About Innovate BC, www.innovatebc.ca Innovate BC is rebooting BC’s economy by helping innovators build great companies. We deliver cost-effective, high-impact programs to address the biggest pain points of BC businesses. CONTACT: Innovate BC email@example.com
What happened Shares of Global Blood Therapeutics (NASDAQ: GBT) were sinking 8% as of 11:14 a.m. EDT on Thursday. The decline came after the company announced its first-quarter results following the market close on Wednesday.
Investors weren't thrilled with the latest earnings update from eBay (NASDAQ: EBAY). Sure, the online marketplace is benefiting from soaring e-commerce demand for everything ranging from collectible sneakers to automobiles. With that bigger picture in mind, let's look at some takeaways from this past week's first-quarter 2021 earnings report, and what they could mean for shareholders of this highly profitable business.